UroGen Pharma

URGN

NASDAQHealth Care

Income Statement

Total Revenue$90.4M

Gross Profit$81.52M

Operating Income$-96.78M

EBITDA$-110.34M

EBIT$-111.52M

Pre-tax Income$-138.31M

Net Income$-126.87M

Cash Equivalent$163.03M

Total Debt$110.44M

Book Value$1.72M

Book Value Per Share0.04

Return on Equity (ROE)-1319.29%

Return on Assets (ROA)-44.41%

Return on Invested Capital (ROI)-1319.29%

Net Profit Margin-140.35%

Current Ratio6.01

Quick Ratio5.62

Long-Term Debt / Equity0.00